Study Identifies Serum I-FABP as Biomarker for Early Detection of Necrotizing Enterocolitis in Premature Infants

A recent study has identified serum intestinal fatty acid binding protein (I-FABP) as a potential biomarker for detecting necrotizing enterocolitis (NEC) in neonates. Researchers found that levels of I-FABP rise significantly during episodes of intestinal stress, particularly during feeding advancements in newborns. This discovery could play a critical role in improving early detection and intervention strategies for NEC, a severe gastrointestinal condition that primarily affects premature infants.

The study highlights the importance of I-FABP, a molecule previously not widely recognized, as an indicator of intestinal health. Elevated levels of this protein were observed to correlate with increased intestinal stress, which is often associated with the development of NEC. The findings suggest that monitoring I-FABP levels could provide clinicians with valuable insights into the onset and progression of the condition, potentially allowing for earlier diagnosis and treatment. Researchers believe this advancement may contribute to better outcomes for affected neonates by enabling more timely medical interventions.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

Related posts:

Phase 3 Interchangeability Study Data Supports Recent Designation Study Finds Insomnia Linked to Lower Life Satisfaction in Adults With ADHD Traits Study Explores Link Between Gut Microbiota and Mental Health in One in Seven Affected Globally New Statistical Framework and Web Platform Developed to Enhance Analysis of In Vivo Drug Combinations

Author

GOAI